P2 Receptor Inhibitors
P2 receptor inhibitors are compounds that selectively block the action of purinergic P2 receptors, which are cell surface receptors activated by extracellular ATP (adenosine triphosphate) and related nucleotides. P2 receptors are categorized into two main types: P2X receptors (ligand-gated ion channels) and P2Y receptors (G protein-coupled receptors). These receptors are involved in a wide range of physiological processes, including neurotransmission, inflammation, immune response, and cell proliferation. By inhibiting P2 receptors, these inhibitors can modulate purinergic signaling pathways and have potential therapeutic applications in conditions such as chronic pain, inflammatory diseases, cardiovascular disorders, and neurodegenerative diseases. Selective P2 receptor inhibitors have been developed to target specific receptor subtypes, allowing for precise modulation of purinergic signaling without affecting other cellular processes unnecessarily.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:2 Page 1 of 1 1
